title: Inhibition of protein synthesis but not β-adrenergic receptors blocks reconsolidation of a cocaine-associated cue memory.
abstract: Previously consolidated memories have the potential to enter a state of lability upon memory recall, during which time the memory can be altered before undergoing an additional consolidation-like process and being stored again as a long-term memory. Blocking reconsolidation of aberrant memories has been proposed as a potential treatment for psychiatric disorders including addiction. Here we investigated of the effect of systemically administering the protein synthesis inhibitor cycloheximide or the β-adrenergic antagonist propranolol on reconsolidation. Rats were trained to self-administer cocaine, during which each lever press resulted in the presentation of a cue paired with an intravenous infusion of cocaine. After undergoing lever press extinction to reduce operant responding, the cue memory was reactivated and rats were administered systemic injections of propranolol, cycloheximide, or vehicle. Post-reactivation cycloheximide, but not propranolol, resulted in a reactivation-dependent decrease in cue-induced reinstatement, indicative of reconsolidation blockade by protein synthesis inhibition. The present data indicate that systemically targeting protein synthesis as opposed to the β-adrenergic system may more effectively attenuate the reconsolidation of a drug-related memory and decrease drug-seeking behavior.
authors.affiliation: Department of Psychiatry, Division of Molecular Psychiatry, New Haven, Connecticut 06520, USA Department of Psychology, Yale University, New Haven, Connecticut 06520, USA.
authors.forename: Amber B
authors.initials: AB
authors.lastname: Dunbar
authors.affiliation: Department of Psychiatry, Division of Molecular Psychiatry, New Haven, Connecticut 06520, USA Department of Psychology, Yale University, New Haven, Connecticut 06520, USA Interdepartmental Neuroscience Program, Yale University, New Haven, Connecticut 06520, USA jane.taylor@yale.edu.
authors.forename: Jane R
authors.initials: JR
authors.lastname: Taylor
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000818:Animals; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects; D003463:Cues; D003513:Cycloheximide / Q000008:administration & dosage; D008297:Male; D000069077:Memory Consolidation / Q000187:drug effects / Q000502:physiology*; D011939:Mental Recall / Q000187:drug effects / Q000502:physiology*; D011433:Propranolol / Q000008:administration & dosage; D011500:Protein Synthesis Inhibitors / Q000008:administration & dosage*; D017207:Rats, Sprague-Dawley; D011943:Receptors, Adrenergic, beta / Q000502:physiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D011500:Protein Synthesis Inhibitors; D011943:Receptors, Adrenergic, beta; D003513:Cycloheximide; D011433:Propranolol; D003042:Cocaine